Prognostic value of red cell distribution width in patients with pulmonary embolism

Clinical and Applied Thrombosis/Hemostasis

Volumn 20, Issue 4, 2014, Pages 365-370

  Ozsu, Savas ^a   Abul, Yasin ^a   Gunaydin, Selda ^a   Orem, Asim ^a   Ozlu, Tevfik ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

mortality; pulmonary embolism; red cell distribution width

Indexed keywords

TROPONIN T; BIOLOGICAL MARKER;

ADULT; ADVERSE OUTCOME; AGED; AREA UNDER THE CURVE; ARTICLE; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTERIZED TOMOGRAPHY PULMONARY ANGIOGRAPHY; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HEART FAILURE; HUMAN; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RED BLOOD CELL DISTRIBUTION WIDTH; BLOOD; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ERYTHROCYTE INDICES; HUMANS; MIDDLE AGED; PROGNOSIS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84899002194     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612464901     Document Type: Article

References (22)

1. Dabbah S, Hammerman H, Markiewicz W, Aronson D. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010 ; 105 (3). 312-317
2. Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L. Red cell distribution width: a powerful prognostic marker in heart failure. Eur J Heart Fail. 2010 ; 12 (4). 415
3. Pascual-Figal DA, Bonaque JC, Redondo B, et al. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail. 2009 ; 11 (9). 840-846
4. Wang F, Pan W, Pan S, Ge J, Wang S, Chen M. Red cell distribution width as a novel predictor of mortality in İCU patients. Ann Med. 2011 ; 43 (1). 40-46
5. Rhodes CJ, Wharton J, Howard LS, Gibbs JS, Wilkins MR. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart. 2011 ; 97 (13). 1054-1060
6. Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009 ; 158 (4). 659-666
7. Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008 ; 264 (4). 295-314
8. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 ; 336 (14). 973-979
9. Zee RY, Glynn RJ, Cheng S, Steiner L, Rose L, Ridker PM. An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: the women's genome health study. Circ Cardiovasc Genet. 2009 ; 2 (1). 57-62
10. Folsom AR, Lutsey PL, Astor BC, Cushman M. C-reactive protein and venous thromboembolism. A prospective investigation in the aric cohort. Thromb Haemost. 2009 ; 102 (4). 615-619
11. Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost. 2005 ; 94 (2). 362-365
12. Sailer T, Vormittag R, Pabinger I, et al. Inflammation in patients with lupus anticoagulant and implications for thrombosis. J Rheumatol. 2005 ; 32 (3). 462-468
13. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009 ; 133 (4). 628-632
14. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the european society of cardiology (ESC). Eur Heart J. 2008 ; 29 (18). 2276-2315
15. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005 ; 172 (8). 1041-1046
16. Jimenez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010 ; 170 (15). 1383-1389
17. West J, Goodacre S, Sampson F. The value of clinical features in the diagnosis of acute pulmonary embolism: systematic review and meta-analysis. QJM. 2007 ; 100 (12). 763-769
18. Donze J, Labarere J, Mean M, Jimenez D, Aujesky D. Prognostic importance of anaemia in patients with acute pulmonary embolism. Thromb Haemost. 2011 ; 106 (2). 289-295
19. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009 ; 169 (5). 515-523
20. Abul Y, Karakurt S, Ozben B, Toprak A. C-reactive protein in acute pulmonary embolism. J Investig Med. 2011 ; 59 (1). 8-14
21. Glynn RJ, Danielson E, Fonseca FA, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009 ; 360 (18). 1851-1861
22. Venetz C, Jimenez D, Mean M, Aujesky D. A comparison of the original and simplified pulmonary embolism severity index. Thromb Haemost. 2011 ; 106 (3). 423-428